Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers

Aim: BRCA1/2-associated breast and ovarian carcinomas are often regarded as a single entity, assuming that BRCA1 and BRCA2 genes are almost equivalent with regard to their clinical significance. However, BRCA1 and BRCA2 genes differ in their function; therefore, a comparison of treatment outcomes in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Anna Sokolenko, Tatiana Gorodnova, Diana Enaldieva, Anna Shestakova, Alexandr Ivantsov, Anna Nyuganen, Igor Berlev, Petr Krivorotko, Alexey Belyaev, Evgeny Imyanitov
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Open Exploration Publishing Inc. 2025-06-01
Saila:	Exploration of Targeted Anti-tumor Therapy
Gaiak:	brca1 brca2 breast cancer pathologic complete response neoadjuvant chemotherapy ovarian cancer
Sarrera elektronikoa:	https://www.explorationpub.com/uploads/Article/A1002325/1002325.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!